Interestingly, the clinical data analysis from TCGA further validated these findings, revealing that patients with HCC with high expression of the CXCR4 or MIF genes exhibit a trend toward shorter OS time and poorer prognosis (Fig. S2C,D). This evidence concerns the gene CXCR4 and hepatocellular carcinoma.